GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Qilian International Holding Group Ltd (NAS:QLI) » Definitions » Forward PE Ratio

Qilian International Holding Group (Qilian International Holding Group) Forward PE Ratio : 0.00 (As of May. 14, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Qilian International Holding Group Forward PE Ratio?

Qilian International Holding Group's Forward PE Ratio for today is 0.00.

Qilian International Holding Group's PE Ratio without NRI for today is 0.00.

Qilian International Holding Group's PE Ratio for today is 0.00.


Qilian International Holding Group Forward PE Ratio Historical Data

The historical data trend for Qilian International Holding Group's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qilian International Holding Group Forward PE Ratio Chart

Qilian International Holding Group Annual Data
Trend
Forward PE Ratio

Qilian International Holding Group Semi-Annual Data
Forward PE Ratio

Competitive Comparison of Qilian International Holding Group's Forward PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Qilian International Holding Group's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Qilian International Holding Group's Forward PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Qilian International Holding Group's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Qilian International Holding Group's Forward PE Ratio falls into.



Qilian International Holding Group Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.


Qilian International Holding Group  (NAS:QLI) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


Qilian International Holding Group Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of Qilian International Holding Group's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Qilian International Holding Group (Qilian International Holding Group) Business Description

Traded in Other Exchanges
N/A
Address
Jiuquan Economic and Technological Development Zone, Gansu Province, Jiuquan, CHN, 735000
Qilian International Holding Group Ltd is a pharmaceutical and chemical company. The company is engaged in the development, manufacture, marketing, and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives products, heparin products, sausage casings, and fertilizers. It operates through three segments namely, Oxytetracycline and Licorice products and TCMD; Fertilizer; and Heparin products and Sausage casing. Oxytetracycline and Licorice products and TCMD segment generates majority of the revenue.

Qilian International Holding Group (Qilian International Holding Group) Headlines

From GuruFocus